The company is recalling certain lots of its insulin patch pumps after finding a small tear in the internal tubing may cause ...

As the Centers for Medicare and Medicaid Services calls for public feedback on how to stop lab test fraud, experts say a ...

The medtech company, which identified the attack on Wednesday, revealed in an update that its order processing, manufacturing and shipping have been disrupted.

MiniMed, Medtronic’s diabetes tech spinoff, made its debut on the public markets Friday. The company started trading on the ...

The robotics company, which has taken steps to preserve cash amid the latest change of course in the development of its ...

Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device ...

The full scope of the impact, including operational and financial effects, is not yet known. Stryker does not have a timeline for full restoration of its systems.

The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.

The surgical robotics firm said that an unauthorized third party accessed customer business and contact information, as well as employee and corporate data.

Biocare’s strong growth in immunohistochemistry is expected to strengthen Agilent’s ability to develop new in vitro diagnostic antibodies.

Haag, who has worked at Medtronic for 20 years, will also serve on the leadership team for the neuroscience group.

The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.